Lmr Partners LLP Eli Lilly & CO Put Options Transaction History

Lmr Partners LLP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $11.6 Million - $13.7 Million	22,100 Added 88.76%	47,000 $27.4 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $67.8 Million - $93.4 Million	-155,900 Reduced 86.23%	24,900 $13.4 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $63.4 Million - $84.8 Million	180,800 New	180,800 $84.8 Million

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.